Abstract | OBJECTIVE: METHODS: We present a detailed case report with the clinical, imaging, and laboratory findings of the patient. The pertinent literature is also reviewed. RESULTS: A 17-year-old patient was known to have CAH due to 21-hydroxylase deficiency. Since the second month of her gestational age, her mother was treated with cortisone-replacement therapy. The patient was treated with hydrocortisone and fludrocortisone since the neonatal period. Her pertinent history included a bilateral adrenalectomy at the age of 13 years in 2006, and for 3 years she led a normal puberty life with no complaint with hormonal replacement therapy. Nevertheless, in 2009, she developed a virilizing syndrome. Subsequently, she underwent surgery in December 2009 for right adnexectomy. However, the regression of the masculinizing mass was not complete and worsened several months after the surgery. A new pelvic magnetic resonance image showed the activation of a contralateral ovarian mass, necessitating a left adnexectomy in August 2010. CONCLUSION: This case demonstrates some interesting features of OART that pose challenges to its management. If an OART is detected early enough and glucocorticoid therapy is received, it is possible that the OART will decrease in size following suppression of adrenocorticotropic hormone levels.
|
Authors | Magda G Zaarour, David M Atallah, Viviane E Trak-Smayra, Georges H Halaby |
Journal | Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
(Endocr Pract)
Vol. 20
Issue 4
Pg. e69-74
(Apr 2014)
ISSN: 1530-891X [Print] United States |
PMID | 24449659
(Publication Type: Journal Article)
|